NeuroOne Medical Technologies

NeuroOne Medical Technologies EV/FCF

The EV/FCF (Enterprise Value to Free Cash Flow) of NeuroOne Medical Technologies (NMTC) as of Oct 27, 2026 is -11.89. In the previous year, EV/FCF (Enterprise Value to Free Cash Flow) was -3.58 — a change of 232.47% (lower).

EV/FCF

-11.89

YoY

232.47%

Last updated:

EV/FCF (Enterprise Value to Free Cash Flow) of NeuroOne Medical Technologies is 2025 -11.89 . EV/FCF (Enterprise Value to Free Cash Flow) of NeuroOne Medical Technologies was 2024 -3.58 . It decreases by 232.47% lower compared to the previous year.

The NeuroOne Medical Technologies EV/FCF history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EV/FCF
Date
EV/FCF
Jan 1, 2018
-14.62 USD
Jan 1, 2019
-7.38 USD
Jan 1, 2020
-10.79 USD
Jan 1, 2021
-3.97 USD
Jan 1, 2022
-3.86 USD
Jan 1, 2023
-2.70 USD
Jan 1, 2024
-3.58 USD
Jan 1, 2025
-11.89 USD
The NeuroOne Medical Technologies EV/FCF history
YEAREV/FCFYoY
-11.89+232.47%
-3.58+32.30%
-2.70-29.94%
-3.86-2.84%
-3.97-63.21%
-10.79+46.20%
-7.38-49.49%
-14.62-95.95%
-361.33-21.98%
-463.15-70.45%
-1,567.43-4.16%
-1,635.39—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

NeuroOne Medical Technologies Stock analysis

What does NeuroOne Medical Technologies do? NeuroOne Medical Technologies Corp., based in Eden Prairie, Minnesota, develops and commercializes thin film electrode technology for medical applications. The company focuses on continuous electroencephalogram (cEEG) and stereoelectrocencephalography (sEEG) recording, spinal cord stimulation, brain stimulation, and ablation solutions for neurological disorders such as epilepsy, Parkinson's disease, and chronic pain. Listed on the stock market in 2012, NeuroOne employs 15 people and explores AI applications in its technology. NeuroOne Medical Technologies is one of the most popular companies on Eulerpool.

Frequently Asked Questions about NeuroOne Medical Technologies stock

EV/FCF (Enterprise Value to Free Cash Flow) of NeuroOne Medical Technologies is -11.89 in 2025.

EV/FCF (Enterprise Value to Free Cash Flow) of NeuroOne Medical Technologies changed from -3.58 to -11.89, representing a 232.47% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EV/FCF (Enterprise Value to Free Cash Flow) NeuroOne Medical Technologies since 2006 – with annual values, charts, and detailed analysis.

The EV/FCF ratio measures the enterprise value relative to free cash flow. It captures the true cash-generating ability of a business.

To evaluate EV/FCF (Enterprise Value to Free Cash Flow)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EV/FCF (Enterprise Value to Free Cash Flow).

A 'good' varies by industry and company stage. On Eulerpool, you can compare EV/FCF (Enterprise Value to Free Cash Flow)'s NeuroOne Medical Technologies with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Valuation — NeuroOne Medical Technologies

P/EP/SEV/EBITP/BP/CFP/FCFPEGEV/RevenueEV/EBITDAEV/FCFEarnings YieldFCF YieldMarket capitalizationEnterprise ValueForward P/EP/TBVShareholder YieldBuyback YieldDiv.-Adj. PEGEV/OCF

All Key Metrics — NeuroOne Medical Technologies